Literature DB >> 15121835

Glucose utilization is essential for hypoxia-inducible factor 1 alpha-dependent phosphorylation of c-Jun.

Keith R Laderoute1, Joy M Calaoagan, Merrill Knapp, Randall S Johnson.   

Abstract

Hypoxia and anoxia are important microenvironmental stresses that contribute to pathological events such as solid-tumor development. We have been investigating the effects of hypoxia and anoxia on expression of the proto-oncogene c-jun and the regulation of c-Jun/AP-1 transcription factors. In earlier work using genetically manipulated mouse embryo fibroblasts (mEFs), we found a functional relationship among c-jun expression, c-Jun N-terminal phosphorylation, and the presence of hypoxia-inducible factor 1 alpha (HIF-1 alpha), the oxygen-regulated subunit of the HIF-1 transcription factor. Both the induction of c-jun mRNA expression and c-Jun N-terminal phosphorylation in cells exposed to hypoxia or anoxia were found to be dependent on the presence of HIF-1 alpha, but this was not the case in cells exposed to less-severe hypoxia. Here we describe new findings concerning HIF-1-dependent c-Jun N-terminal phosphorylation in cells exposed to hypoxia or anoxia. Specifically, we report that hypoxia-inducible c-Jun N-terminal kinase (JNK) activity, which involves JNKs or stress-activated protein kinases (SAPKs), is dependent on enhanced glucose utilization mediated by HIF-1. These results suggest a model in which hypoxia-inducible JNK activity is connected to oxygen sensing through increased glucose absorption and/or glycolytic activity regulated by the HIF-1 system. We also found that basal threonine and tyrosine phosphorylation (within the TEY motif) of extracellular signal-regulated kinases 1 and 2 (ERK1/2) and the corresponding ERK1/2 activity were defective in hypoxic HIF-1 alpha-null mEFs but not in wild-type mEFs, independently of glucose uptake. Therefore, the activities of both JNKs/SAPKs and ERK1/2 are sensitive to HIF-1-dependent processes in cells exposed to hypoxia or anoxia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121835      PMCID: PMC400476          DOI: 10.1128/MCB.24.10.4128-4137.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

Review 1.  The mammalian Jun proteins: redundancy and specificity.

Authors:  F Mechta-Grigoriou; D Gerald; M Yaniv
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 2.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

3.  Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.

Authors:  L Xu; K Xie; N Mukaida; K Matsushima; I J Fidler
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

4.  Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer.

Authors:  Oliver Stoeltzing; Wenbiao Liu; Niels Reinmuth; Fan Fan; Alexander A Parikh; Corazon D Bucana; Douglas B Evans; Gregg L Semenza; Lee M Ellis
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun.

Authors:  Simon Morton; Roger J Davis; Ann McLaren; Philip Cohen
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

6.  Role of ERK and calcium in the hypoxia-induced activation of HIF-1.

Authors:  Denis Mottet; Gaetan Michel; Patricia Renard; Noelle Ninane; Martine Raes; Carine Michiels
Journal:  J Cell Physiol       Date:  2003-01       Impact factor: 6.384

7.  Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes.

Authors:  K A Webster; D J Discher; N H Bishopric
Journal:  J Biol Chem       Date:  1993-08-05       Impact factor: 5.157

Review 8.  New targets of AMP-activated protein kinase.

Authors:  L Hue; C Beauloye; L Bertrand; S Horman; U Krause; A-S Marsin; D Meisse; D Vertommen; M H Rider
Journal:  Biochem Soc Trans       Date:  2003-02       Impact factor: 5.407

9.  Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity.

Authors:  A Lin; J Frost; T Deng; T Smeal; N al-Alawi; U Kikkawa; T Hunter; D Brenner; M Karin
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

10.  Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK).

Authors:  Kay Barnes; Jean C Ingram; Omar H Porras; L Felipe Barros; Emma R Hudson; Lee G D Fryer; Fabienne Foufelle; David Carling; D Grahame Hardie; Stephen A Baldwin
Journal:  J Cell Sci       Date:  2002-06-01       Impact factor: 5.285

View more
  10 in total

1.  Effect of hypoxic stress-activated Polo-like kinase 3 on corneal epithelial wound healing.

Authors:  Jiawei Lu; Ling Wang; Wei Dai; Luo Lu
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-05-26       Impact factor: 4.799

2.  5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

Authors:  Keith R Laderoute; Khalid Amin; Joy M Calaoagan; Merrill Knapp; Theresamai Le; Juan Orduna; Marc Foretz; Benoit Viollet
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  Adaptive myogenesis under hypoxia.

Authors:  Zhong Yun; Qun Lin; Amato J Giaccia
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

4.  Earliest changes in the left ventricular transcriptome postmyocardial infarction.

Authors:  Mark H Harpster; Somnath Bandyopadhyay; D Paul Thomas; Pavel S Ivanov; Jacque A Keele; Natalia Pineguina; Bifeng Gao; Vijay Amarendran; Mark Gomelsky; Richard J McCormick; Mark M Stayton
Journal:  Mamm Genome       Date:  2006-07-14       Impact factor: 2.957

5.  5'-AMP-activated protein kinase (AMPK) supports the growth of aggressive experimental human breast cancer tumors.

Authors:  Keith R Laderoute; Joy M Calaoagan; Wan-Ru Chao; Dominc Dinh; Nicholas Denko; Sarah Duellman; Jessica Kalra; Xiaohe Liu; Ioanna Papandreou; Lidia Sambucetti; Laszlo G Boros
Journal:  J Biol Chem       Date:  2014-07-03       Impact factor: 5.157

6.  Activation of Polo-like kinase 3 by hypoxic stresses.

Authors:  Ling Wang; Jie Gao; Wei Dai; Luo Lu
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

7.  Effect of Hypoxia-regulated Polo-like Kinase 3 (Plk3) on Human Limbal Stem Cell Differentiation.

Authors:  Ling Wang; Sheyla González; Wei Dai; Sophie Deng; Luo Lu
Journal:  J Biol Chem       Date:  2016-06-08       Impact factor: 5.157

8.  In vivo genetic dissection of tumor growth and the Warburg effect.

Authors:  Cheng-Wei Wang; Arunima Purkayastha; Kevin T Jones; Shivani K Thaker; Utpal Banerjee
Journal:  Elife       Date:  2016-09-01       Impact factor: 8.140

9.  Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.

Authors:  Hongliang Li; Jiyeon Lee; Chaoyong He; Ming-Hui Zou; Zhonglin Xie
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-03       Impact factor: 5.900

10.  Identification of Potential Chemical Substrates as Fuel for Hypoxic Tumors That May Be Linked to Invadopodium Formation in Hypoxia-Induced MDA-MB-231 Breast-Cancer Cell Line.

Authors:  Hamad Ali Hamad; Hamid Hammad Enezei; Anmar Alrawas; Noraina Muhamad Zakuan; Nurul Akmaryanti Abdullah; Yoke Kqueen Cheah; Nur Fariesha Md Hashim
Journal:  Molecules       Date:  2020-08-26       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.